Musculoskeletal pain in obese compared with healthy-weight children

Margarita D Tsiros1, Jonathan D Buckley, Peter R C Howe

  • 1*Nutritional Physiology Research Centre, School of Health Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, SA †School of Health Sciences, RMIT University, Melbourne, Vic ‡Mater Mothers' Hospital, Mater Research and Centre for Musculoskeletal Research, Griffith Health Institute, Griffith University, Nathan, QLD, Australia.

Insights

Childhood obesity is linked to more frequent and intense musculoskeletal pain, especially in the lower limbs. Body mass index is a key indicator, highlighting the need for pain screening and tailored exercise in obese children.

Area of Science:

  • Pediatric Health
  • Musculoskeletal Disorders
  • Obesity Research

Background:

  • Childhood obesity is a growing public health concern.
  • Musculoskeletal pain is common in children and can impact quality of life.

Purpose of the Study:

  • To determine the association between childhood obesity and musculoskeletal pain.
  • To identify predictors of pain in obese children.

Main Methods:

  • An observational case-control study involving obese and healthy-weight children aged 10-13 years.
  • Pain characteristics were assessed using the Pediatric Pain Questionnaire.
  • Body composition and physical activity were measured using dual-energy x-ray absorptiometry and accelerometry.

Main Results:

  • Obese children reported more intense pain, pain in more locations, and higher prevalence of lower limb pain compared to healthy-weight children.
  • Body mass index was significantly associated with increased pain locations and intensity.
  • Percent body fat did not show a significant relationship with pain variables.

Conclusions:

  • Childhood obesity is associated with increased musculoskeletal pain, particularly in the lower limbs.
  • Body mass index is a stronger predictor of pain than overall adiposity.
  • Clinicians should screen obese children for pain and incorporate symptom-aware exercise programs.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330